← FDA DRUG APPROVALS

FDA ANDA · ANDA077630

TAMSULOSIN HYDROCHLORIDE

Sponsor: TEVA PHARMS

APPLICATION
ANDA077630
TYPE
ANDA
ORIGINAL APPROVAL
2010-04-27
LATEST ACTION
2015-12-08
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

TAMSULOSIN HYDROCHLORIDEPrescription
TAMSULOSIN HYDROCHLORIDE 0.4MG · CAPSULE · ORAL

Approval history

2015-12-08Labeling · Supplement 7 · standardAP
2015-12-08Labeling · Supplement 6 · standardAP
2011-08-30Labeling · Supplement 3AP
2010-04-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →